ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,179.20
0.60%
S&P 500
5,308.13
0.09%
US Dollar vs CAD
1.36397
0.12%
Bitcoin
71,315.87
-0.18%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Eagle Pharmaceuticals Inc (EGRX)

  7. Eagle Pharmaceuticals Inc (EGRX) News

EGRX

Eagle Pharmaceuticals (EGRX)

Eagle Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EGRX
DateTimeSourceHeadlineSymbolCompany
05/15/20248:29AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
05/10/20244:27PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:EGRXEagle Pharmaceuticals Inc
03/08/20243:49PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
03/01/20243:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
03/01/20246:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
02/29/20247:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
02/29/20243:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
02/29/20247:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
02/14/20244:09PMEdgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:EGRXEagle Pharmaceuticals Inc
02/13/20242:53PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EGRXEagle Pharmaceuticals Inc
02/13/20247:50AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
02/12/202412:38PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:EGRXEagle Pharmaceuticals Inc
02/09/20244:45AMPR Newswire (US)Eagle Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 9, 2024 to Discuss Your Rights - EGRXNASDAQ:EGRXEagle Pharmaceuticals Inc
02/07/20248:15AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:EGRXEagle Pharmaceuticals Inc
02/06/20244:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
02/02/20244:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX)NASDAQ:EGRXEagle Pharmaceuticals Inc
01/26/202410:49AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EGRXEagle Pharmaceuticals Inc
01/26/20244:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX)NASDAQ:EGRXEagle Pharmaceuticals Inc
01/19/20244:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX)NASDAQ:EGRXEagle Pharmaceuticals Inc
01/18/20245:56AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
01/18/20245:50AMGlobeNewswire Inc.Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property PortfolioNASDAQ:EGRXEagle Pharmaceuticals Inc
01/16/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
01/12/20244:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX)NASDAQ:EGRXEagle Pharmaceuticals Inc
01/09/20244:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
01/09/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
01/05/20244:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX)NASDAQ:EGRXEagle Pharmaceuticals Inc
12/22/20236:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
12/22/20234:15PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:EGRXEagle Pharmaceuticals Inc
12/20/20233:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
12/18/20234:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX)NASDAQ:EGRXEagle Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:EGRX

Your Recent History

USOTC
ECSL
Ecare Solutions (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
MGON
Megola (PK)
USOTC
TGLO
TheGlobe com (PK)
USOTC
ENZC
Enzolytics (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
SFLM
SFLMaven (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
IBGR
Nexus Energy Services (PK)
USOTC
AFFU
Affluence (PK)
USOTC
SONGD
Music Licensing
NASDAQ
COOP
Mr Cooper
USOTC
LQMT
Liquidmetal Technologies (QB)
NASDAQ
NB
NioCorp Developments
USOTC
FSRN
Fisker (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved